Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-05

Clinical Trial Results: Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa

View source ↗

Summary

A completed clinical trial evaluating the population effectiveness of dolutegravir implementation for HIV-1 infection in Sub-Saharan Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV-1-infection | Status: COMPLETED | Results posted: 2026-08-05